Clinical trial
Research of Exenatide for Overweight/Obese PCOS Patients With IGR
NCT03352869
Study timeline
Study start (actual)2017-11-28Date precision: day
Registry last updated2019-09-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Polycystic Ovary Syndromeunresolved
Overweight and Obesityunresolved
Disorder of Glucose Regulationunresolved
Interventions
ExenatideDRUG · verified · RxNorm: exenatide
MetforminDRUG · verified · RxNorm: metformin
Sponsors & collaborators
RenJi Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03352869 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.